New Open Science partnership will pave way for better treatments, faster
NeuroSGC created to increase volume and quality of cell assays for drug discoveryA new partnership between the Structural Genomics Consortium (SGC) and the Montreal Neurological Institute and Hospital (The Neuro) will use a unique open science framework to help scientists discover new targets for drug development for neurological diseases.
The MNI forms promising Open Science partnership with Takeda
Industry and academia team up for the benefit of people suffering from ALSA unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.
Onward to Open Science
The Neuro to launch open research publishing platform with F1000A new partnership between The Neuro and F1000 will create a publishing platform for researchers that will speed the progress of neuroscience discovery.